AA
IMUC

Ancora Advisors’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Ancora Advisors’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-50
Closed – – 1369
2018
Q3 		$0 Buy
+50
New +$12 ﹤0.01% 1375

Other funds holding IMUC

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return